Alaunos Therapeutics, Inc. - Common stock (TCRT)
CUSIP: 98973P309
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common stock
- Shares outstanding
- 2,198,384
- Total 13F shares
- 125,752
- Share change
- +17,511
- Total reported value
- $359,538
- Price per share
- $2.86
- Number of holders
- 28
- Value change
- +$50,029
- Number of buys
- 9
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 98973P309?
CUSIP 98973P309 identifies TCRT - Alaunos Therapeutics, Inc. - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 98973P309:
Top shareholders of TCRT - Alaunos Therapeutics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Robert W. Postma |
13D/G
|
Postma Robert W |
9%
|
199,796
|
$615,372 | $0 | 24 Jun 2025 | |
| Price Adrian |
13D/G
|
— |
8.6%
|
189,061
|
$491,559 | $0 | 24 Feb 2026 | |
| Kevin S. Boyle Sr. |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
798,236
|
$111,993 | — | 01 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
30,061
|
$97,096 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.97%
|
21,353
|
$68,970 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
19,736
|
$63,758 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.85%
|
18,588
|
$60,039 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.57%
|
12,602
|
$40,000 | — | 31 Dec 2025 | |
| Raffaele Baffa |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
280,645
|
$39,374 | — | 17 May 2021 | |
| Ferdinand Groenewald |
3/4/5
|
Vice President of Finance |
—
mixed-class rows
|
14,775
mixed-class rows
|
$30,924 | — | 18 Aug 2025 | |
| Heidi Hagen |
3/4/5
|
Director |
—
class O/S missing
|
145,889
|
$20,468 | — | 02 Sep 2021 | |
| Christopher Bowden |
3/4/5
|
Director |
—
mixed-class rows
|
144,167
mixed-class rows
|
$6,197 | — | 22 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
1,647
|
$5,320 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
1,309
|
$4,229 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.05%
|
1,081
|
$3,492 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
1,076
|
$3,474 | — | 31 Dec 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
300
|
$969 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
178
|
$574 | — | 31 Dec 2025 | |
| Blue Trust, Inc. |
13F
|
Company |
0.01%
|
135
|
$436 | — | 31 Dec 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
92
|
$297 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
89
|
$287 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
89
|
$287 | — | 31 Dec 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
70
|
$226 | — | 31 Dec 2025 | |
| Key FInancial Inc |
13F
|
Company |
0%
|
24
|
$78 | — | 31 Dec 2025 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
23
|
$74 | — | 31 Dec 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
21
|
$68 | — | 31 Dec 2025 | |
| NBC SECURITIES, INC. |
13F
|
Company |
0%
|
20
|
$64 | — | 31 Dec 2025 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
19
|
$61 | — | 31 Dec 2025 | |
| Inspire Investing, LLC |
13F
|
Company |
0%
|
10
|
$34 | — | 31 Dec 2025 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
10
|
$32 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
6
|
$19 | — | 31 Dec 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
2
|
$6 | — | 31 Dec 2025 | |
| TUCKER ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
1
|
$3 | — | 31 Dec 2025 | |
| Eleanor de Groot |
3/4/5
|
EVP, Operations |
—
class O/S missing
|
350,000
|
— | — | 30 Mar 2022 | |
| Abhishek K. Srivastava |
3/4/5
|
Vice President, Technical Operations |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Drew Deniger |
3/4/5
|
Vice President, Research and Development |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Michael Wong |
3/4/5
|
Vice President, Finance |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| James Huang |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Mary Thistle |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Holger Weis |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
13,676
|
— | — | 18 Aug 2025 | |
| Robert Hofmeister |
3/4/5
|
Director |
—
class O/S missing
|
12,800
|
— | — | 06 Jun 2024 | |
| Dale Curtis Hogue Jr. |
3/4/5
|
Chief Executive Officer, Interim, Director |
—
class O/S missing
|
3,000
|
— | — | 29 Mar 2025 | |
| Melinda Lackey |
3/4/5
|
Legal & Administration |
—
class O/S missing
|
1,000
|
— | — | 29 Mar 2025 |
Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) as of Q1 2026
As of 31 Mar 2026,
Alaunos Therapeutics, Inc. - Common stock (TCRT) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
125,752 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., VANGUARD FIDUCIARY TRUST CO, VANGUARD CAPITAL MANAGEMENT LLC, HRT FINANCIAL LP, TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC, XTX Topco Ltd, UBS Group AG, and OSAIC HOLDINGS, INC..
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
26
Q1 2026 holders
28
Holder diff
2
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.